« Back
Home /
Gemcitabine elaidate

Gemcitabine elaidate

Item no.	V4887-25mg
Manufacturer	InvivoChem LLC
CASRN	210829-30-4
Amount	25 mg
Quantity options	100 mg 250 mg 500 mg 50 mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	210829-30-4
Available
Description	InvivoChem Cat #:V4887CAS #:210829-30-4Purity >=98% Description: Gemcitabine elaidate (formerly know as CP-4126 and CO-101) is a potent, lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), which is an antimetabolite deoxynucleoside analogue with potential antineoplastic activity. Upon hydrolysis intracellularly by esterases, the prodrug gemcitabine is converted into the active metabolites difluorodeoxycytidine di- and tri-phosphate (dFdCDP and dFdCTP) by deoxycytidine kinase. dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis. Description: Gemcitabine elaidate (formerly know as CP-4126 and CO-101) is a potent, lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), which is an antimetabolite deoxynucleoside analogue with potential antineoplastic activity. Upon hydrolysis intracellularly by esterases, the prodrug gemcitabine is converted into the active metabolites difluorodeoxycytidine di- and tri-phosphate (dFdCDP and dFdCTP) by deoxycytidine kinase. dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis.Description References: J Clin Oncol. 2013 Dec 10; 31(35):4453-61. References: J Clin Oncol. 2013 Dec 10; 31(35):4453-61. References: J Clin Oncol. 2013 Dec 10; 31(35):4453-61. References CAS : 95058-81-4 (free base); 122111-03-9 (HCl); 116371-67-6 (Gemcitabine monophosphate free acid); 1638288-31-9 (Gemcitabine monophosphate disodium salt); 840506-29-8 Acelarin (NUC-1031) is a ProTide transformation and enhancement of the widely-used nucleoside analogue, gemcitabine; 892128-60-8 (LY2334737, an orally bioavailable prodrug of gemcitabine) CAS : 95058-81-4 (free base); 122111-03-9 (HCl); 116371-67-6 (Gemcitabine monophosphate free acid); 1638288-31-9 (Gemcitabine monophosphate disodium salt); 840506-29-8 Acelarin (NUC-1031) is a ProTide transformation and enhancement of the widely-used nucleoside analogue, gemcitabine; 892128-60-8 (LY2334737, an orally bioavailable prodrug of gemcitabine)CAS : 95058-81-4 (free base); 122111-03-9 (HCl); 116371-67-6 (Gemcitabine monophosphate free acid); 1638288-31-9 (Gemcitabine monophosphate disodium salt); 840506-29-8 Acelarin (NUC-1031) is a ProTide transformation and enhancement of the widely-used nucleoside analogue, gemcitabine; 892128-60-8 (LY2334737, an orally bioavailable prodrug of gemcitabine)
	Name: Gemcitabine elaidate CAS#: 210829-30-4 Chemical Formula: C27H43F2N3O5 Exact Mass: 527.31708 Molecular Weight: 527.644 Elemental Analysis: C, 61.46; H, 8.21; F, 7.20; N, 7.96; O, 15.16
Storage	-20C for 3 years in powder form
	-80C for 2 years in solvent
Technical Information	8

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Delivery expected until 10/2/2025

Express Delivery: Save 16 days

Compare

Add to wishlist

Get an offer